Evolutec Limited
Records under this name other than the patents Evolutec Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 8 of 8 · Back to Evolutec Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,993,264 | Complement inhibitors Formerly held Term ended Term ended Jan 15, 2026 · From the USPTO record | Term ended | Term ended Jan 15, 2026 | From the USPTO record |
| US 7,884,188 | Complement inhibitors Formerly held Term ended Term ended Dec 12, 2025 · From the USPTO record | Term ended | Term ended Dec 12, 2025 | From the USPTO record |
| US 7,335,733 | Tissue Cement Proteins from Rhipicephalus Appendiculatus Formerly held Term ended Term ended Nov 12, 2018 · Medium confidence | Term ended | Term ended Nov 12, 2018 | Medium confidence |
| US 6,987,168 | Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites Lapsed on the fee record Ended Jan 17, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jan 17, 2014 | From the USPTO record |
| US 7,439,229 | Cytokine activity regulator molecules from tick salivary glands Lapsed on the fee record Ended Oct 21, 2012 · From the USPTO record | Lapsed on the fee record | Ended Oct 21, 2012 | From the USPTO record |
| US 7,279,276 | Screening method Lapsed on the fee record Ended Oct 9, 2011 · From the USPTO record | Lapsed on the fee record | Ended Oct 9, 2011 | From the USPTO record |
| US 6,794,360 | Treatment of allergic rhinitis Lapsed on the fee record Ended Sep 21, 2008 · From the USPTO record | Lapsed on the fee record | Ended Sep 21, 2008 | From the USPTO record |
| US 6,737,399 | Treatment of conjunctivitis Lapsed on the fee record Ended May 18, 2008 · From the USPTO record | Lapsed on the fee record | Ended May 18, 2008 | From the USPTO record |